Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Penland

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 7, 2011
Evaluation of the disease liability of CFTR variantsPatrick R Sosnay, Carlo Castellani, Mary Corey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 30, 2015
Bias in CFTR screening panelsPatrick R Sosnay, Carlo Castellani, Christopher M Penland, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2022
Caution advised in the use of CFTR modulator treatment for individuals harboring specific CFTR variantsKaren S Raraigh, Michelle H Lewis, Joseph M Collaco, et al.
Seminars in Respiratory and Critical Care Medicine|September 18, 2009
A pipeline of therapies for cystic fibrosisMelissa A Ashlock, Robert J Beall, Nicole M Hamblett, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 7, 2011
CFTR Folding Consortium: methods available for studies of CFTR folding and correctionKathryn W Peters, Tsukasa Okiyoneda, William E Balch, et al.
Nature Genetics|August 27, 2013
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator genePatrick R Sosnay, Karen R Siklosi, Fredrick Van Goor, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 7, 2011
Evaluation of the disease liability of CFTR variantsPatrick R Sosnay, Carlo Castellani, Mary Corey, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 30, 2015
Bias in CFTR screening panelsPatrick R Sosnay, Carlo Castellani, Christopher M Penland, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2022
Caution advised in the use of CFTR modulator treatment for individuals harboring specific CFTR variantsKaren S Raraigh, Michelle H Lewis, Joseph M Collaco, et al.
Seminars in Respiratory and Critical Care Medicine|September 18, 2009
A pipeline of therapies for cystic fibrosisMelissa A Ashlock, Robert J Beall, Nicole M Hamblett, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 7, 2011
CFTR Folding Consortium: methods available for studies of CFTR folding and correctionKathryn W Peters, Tsukasa Okiyoneda, William E Balch, et al.
Nature Genetics|August 27, 2013
Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator genePatrick R Sosnay, Karen R Siklosi, Fredrick Van Goor, et al.
Pageof 1